Anavex Life Sciences Corp (AVXL)

[falconer66a]

They know...and understand.

Could it be BIIB and its BOD understands what is going to happen in 2022-3 time period with the Anavex proof of concept that the BIIB magic is gone come 2024?

Let’s see, any chance the scientific insiders at Biogen have not had the time, or not had access to read the multitude of papers and presentations telling the details of Anavex science?

Inside of Biogen there must be an enforced policy prohibiting anyone there from checking any or all of the science postings on the Anavex website. Perhaps Biogen has the same sort of experts we have contributing so usefully with posts to this board telling all of the errors and failings of the purported Anavex science.

Consequently, they have no worries about Anavex being a competitor in 2022 and on out. Nothing in the Anavex barn worth worrying about. The clinical trials will fail, no New Drug Applications (NDAs) will be submitted to the FDA. Sigma-1 receptor biology will be more accurately understood to have no useful, extraneous activating ligands. In 2022 blarcamesine will fade, be relegated to merely a failed story of unfounded hope and vision.

Or...?

Biogen technicians can read and understand the presented Anavex science as well as any of us here can.

Let the reader discern.